FAQ
Q.
How do I gain access to the Rx for Change materials?
A.
The program materials can be downloaded from our Web-site. All persons who receive any component of the Rx for Change program must complete the online registration process which includes acceptance of our end-user license agreement.
Q.
How much do the materials cost?
A.
We provide all materials at no cost.
Q.
The Rx for Change program was created for pharmacy students. Can it be used with students in other health disciplines?
A.
Yes. Our materials are appropriate for all health disciplines.
Q.
Can the materials be used to train licensed health care professionals?
A.
Yes. Although Rx for Change was designed for the training of students in the health professions, the program also has been used for training licensed health professionals. We recommend a 6- to 8-hour workshop, but abbreviated versions also are available. We provide learning objectives, slides, and audience handouts.
Q.
Have the Rx for Change materials been externally reviewed?
A.
Yes, our materials have undergone two rounds of external review. Our external reviewers are:
Neal Benowitz, MD, University of California San Francisco School of Medicine
Bruce A. Berger, PhD, RPh, Auburn University School of Pharmacy
Li Cheng, PhD, City of Hope National Medical Center
Timothy Cline, PhD, formerly at University of California Los Angeles
Carlo C. DiClemente, PhD, University of Maryland Baltimore County
Stanton A. Glantz, PhD, University of California San Francisco
Taline Khroyan, PhD, Center for Health Sciences, SRI International
Alexander V. Prokhorov, MD, PhD, M.D. Anderson Cancer Center
Frank Vitale, MA, University of Pittsburgh School of Pharmacy
Bruce A. Berger, PhD, RPh, Auburn University School of Pharmacy
Li Cheng, PhD, City of Hope National Medical Center
Timothy Cline, PhD, formerly at University of California Los Angeles
Carlo C. DiClemente, PhD, University of Maryland Baltimore County
Stanton A. Glantz, PhD, University of California San Francisco
Taline Khroyan, PhD, Center for Health Sciences, SRI International
Alexander V. Prokhorov, MD, PhD, M.D. Anderson Cancer Center
Frank Vitale, MA, University of Pittsburgh School of Pharmacy
Q.
Are there instructions describing how to implement the Rx for Change program?
A.
Yes. We have created a comprehensive Faculty Coordinator's Guide - this document provides a complete description of all facets of program implementation.
Q.
Do you conduct train-the-trainer programs?
A.
Yes, upon request. To schedule a training or to inquire about future trainings, contact us at rxfc@pharmacy.ucsf.edu.
Q.
Who can use the Rx for Change materials?
A.
We openly share our materials with all educators and encourage their use within the bounds specified in the End-User Licensing Agreement.
Q.
Once I receive access to the Rx for Change materials, can I share the electronic files, materials, and/or my Web access codes with others?
A.
No; if others wish to use the Rx for Change materials, please advise them to initiate their own online account. The End-User Licensing Agreement permits you to reproduce, distribute, perform publicly and display publicly the Rx for Change materials for non-commercial, not-for-profit educational use only. Specific information about the use of the Rx for Change materials is detailed in the End-User Licensing Agreement.
Q.
Who owns the Rx for Change materials?
A.
The program materials were developed through a collaborative effort and are owned jointly by the University of California, the University of Southern California, and Western University of Health Sciences. The copyright is represented by The Regents of the University of California.
Q.
Who are the primary developers of the Rx for Change Program content?
A.
The primary Rx for Change developers are:
Eunice Chung, PharmD, Western University of Health Sciences
Robin L. Corelli, PharmD, UCSF School of Pharmacy
Christine M. Fenlon, BFA, Purdue University School of Pharmacy
Sebastien C. Fromont, MD, UCSF School of Medicine (psychiatry version)
Karen S. Hudmon, DrPH, MS, RPh, Purdue University School of Pharmacy
Lisa A. Kroon, PharmD, UCSF School of Pharmacy
Judith J. Prochaska, PhD, UCSF School of Medicine (psychiatry version)
Leanne M. Sakamoto, PharmD, currently at Cedars-Sinai Medical Center
Robin L. Corelli, PharmD, UCSF School of Pharmacy
Christine M. Fenlon, BFA, Purdue University School of Pharmacy
Sebastien C. Fromont, MD, UCSF School of Medicine (psychiatry version)
Karen S. Hudmon, DrPH, MS, RPh, Purdue University School of Pharmacy
Lisa A. Kroon, PharmD, UCSF School of Pharmacy
Judith J. Prochaska, PhD, UCSF School of Medicine (psychiatry version)
Leanne M. Sakamoto, PharmD, currently at Cedars-Sinai Medical Center
Other contributors include:
Theresa M. Bayt, MD, Roudebush VA – Indianapolis (cancer version)
Janet Brigham, PhD, Center for Health Sciences, SRI International
Karen W. Cullen, PhD, RD, Baylor College of Medicine
Lowell C. Dale, MD, Mayo Clinic (anesthesiology version)
Brion Fox, JD, University of Wisconsin
Herbert Severson, PhD, Oregon Research Institute
Frank Vitale, MA, University of Pittsburgh School of Pharmacy
David O. Warner, MD, Mayo Clinic (anesthesiology version)
Clifford Watson, PhD, Centers for Disease Control and Prevention
Alan Zillich, PharmD, Purdue University School of Pharmacy
Theresa M. Bayt, MD, Roudebush VA – Indianapolis (cancer version)
Janet Brigham, PhD, Center for Health Sciences, SRI International
Karen W. Cullen, PhD, RD, Baylor College of Medicine
Lowell C. Dale, MD, Mayo Clinic (anesthesiology version)
Brion Fox, JD, University of Wisconsin
Herbert Severson, PhD, Oregon Research Institute
Frank Vitale, MA, University of Pittsburgh School of Pharmacy
David O. Warner, MD, Mayo Clinic (anesthesiology version)
Clifford Watson, PhD, Centers for Disease Control and Prevention
Alan Zillich, PharmD, Purdue University School of Pharmacy
Q.
What funding organizations have supported the Rx for Change program?
A.
The Rx for Change program was developed almost entirely through volunteer efforts of faculty across California. Limited funds were available from the California Department of Health Services, Tobacco Control Section (grant 94-20949-02 to the Pharmacy Partnership, California Medical Association Foundation) and the University of California San Francisco Instructional Grants Program (to R Corelli), primarily to support the program's external review, graphics work, medical editing, and data entry.
The University of California Tobacco-Related Disease Research Program provided funding for the early phases of our program evaluation (grant 8BT-2301 to K Hudmon and M Shreve) and also kindly provided bridging support (grant 10ST-0339 to K Hudmon) to facilitate finalization of the program until additional funding was received from the National Cancer Institute (grant 1 R25 CA90720 to K Hudmon) for national dissemination. Rx for Change in Psychiatry also has been funded by the California TRDRP (grant 13KT-0152 to J Prochaska).
The Smoking Cessation Leadership Center at the University of California San Francisco, through funding from the Robert Wood Johnson Foundation, has assisted with ongoing dissemination of the Rx for Change program.
Q.
What's the story behind the petition against tobacco sales in pharmacies, on the main page of your Web-site?
A.
For several years, our research team has been engaged in an effort to eliminate tobacco sales in pharmacies. We hope that a collective list (banding together the voices of pharmacists, pharmacy students, other health professionals, consumers, etc.) will raise awareness and ultimately remove the single most important cause of preventable death in our country from our pharmacy shelves.
- Print
- |
- Text Size
